These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8611366

  • 1. Cyclosporine-induced transient renal hypoperfusion in adolescent transplant recipients.
    Dello Strologo L, Massella L, Rizzoni G.
    Pediatr Nephrol; 1996 Feb; 10(1):81-3. PubMed ID: 8611366
    [Abstract] [Full Text] [Related]

  • 2. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion.
    Ruggenenti P, Perico N, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G.
    Kidney Int; 1993 Mar; 43(3):706-11. PubMed ID: 8455370
    [Abstract] [Full Text] [Related]

  • 3. Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers.
    Bárány P, Stenvinkel P, Ottosson-Seeberger A, Alvestrand A, Morrow J, Roberts JJ, Salahudeen AK.
    Nephrol Dial Transplant; 2001 Mar; 16(3):580-4. PubMed ID: 11239035
    [Abstract] [Full Text] [Related]

  • 4. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK, Sørensen SS, Hansen HE, Pedersen EB.
    Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Renal hemodynamic effects of L-arginine and sodium nitroprusside in heart transplant recipients.
    Koller-Strametz J, Wolzt M, Fuchs C, Putz D, Wisser W, Mensik C, Eichler HG, Laufer G, Schmetterer L.
    Kidney Int; 1999 May; 55(5):1871-7. PubMed ID: 10231449
    [Abstract] [Full Text] [Related]

  • 9. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
    Gaspari F, Perico N, Pisoni R, Anedda MF, Signorini O, Caruso R, Gotti E, Remuzzi G.
    Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute reversal of cyclosporine nephrotoxicity by neutral endopeptidase inhibition in stable renal transplant recipients.
    Lipkin GW, Thuraisingham R, Dawnay AB, Harwood SM, Raine AE.
    Transplantation; 1997 Oct 15; 64(7):1007-17. PubMed ID: 9381523
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients.
    Gaspari F, Anedda MF, Signorini O, Amuchastegui SC, Perico N, Remuzzi G.
    Transplant Proc; 1998 Aug 15; 30(5):1654-5. PubMed ID: 9723229
    [No Abstract] [Full Text] [Related]

  • 14. Fish oil and cyclosporin A-induced renal hypoperfusion in kidney-transplanted patients.
    Hansen JM, Høy CE, Strandgaard S.
    Nephrol Dial Transplant; 1995 Aug 15; 10(9):1745-50. PubMed ID: 8559499
    [Abstract] [Full Text] [Related]

  • 15. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
    Laine J, Jalanko H, Leijala M, Sairanen H, Holmberg C.
    J Heart Lung Transplant; 1997 Dec 15; 16(12):1217-24. PubMed ID: 9436133
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Angiotensin converting enzyme inhibition and chronic cyclosporine-induced renal dysfunction in type 1 diabetes.
    Hannedouche TP, Natov S, Boitard C, Lacour B, Grünfeld JP.
    Nephrol Dial Transplant; 1996 Apr 15; 11(4):673-8. PubMed ID: 8671857
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acute effects of nifedipine in renal transplant recipients treated with cyclosporine or azathioprine.
    Hilbrands LB, Hoitsma AJ, van Hamersvelt HW, Wetzels JF, Huysmans FT, Koene RA.
    Am J Kidney Dis; 1994 Nov 15; 24(5):838-45. PubMed ID: 7977327
    [Abstract] [Full Text] [Related]

  • 20. Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.
    Asberg A, Christensen H, Hartmann A, Berg KJ.
    Clin Transplant; 1998 Oct 15; 12(5):363-70. PubMed ID: 9787942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.